5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | NEUTRAL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.97▲ | 2.93▲ | 2.91▲ | 3.06▼ | 3.61▼ |
MA10 | 2.97▲ | 2.91▲ | 2.97▲ | 3.07▼ | 3.92▼ |
MA20 | 2.95▲ | 2.97▲ | 3.06▼ | 3.57▼ | 3.52▼ |
MA50 | 2.91▲ | 3.06▼ | 3.04▼ | 3.82▼ | 3.91▼ |
MA100 | 2.96▲ | 3.04▼ | 3.20▼ | 3.59▼ | 3.24▼ |
MA200 | 3.05▼ | 3.27▼ | 4.02▼ | 3.77▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.001▼ | 0.006▲ | -0.015▼ | -0.054▼ | -0.048▼ |
RSI | 59.602▲ | 49.251▼ | 46.285▼ | 37.796▼ | 44.395▼ |
STOCH | 35.926 | 41.638 | 22.247 | 36.365 | 38.013 |
WILL %R | -50.000 | -42.593 | -42.593 | -87.407▼ | -88.507▼ |
CCI | 6.049 | 37.656 | -20.910 | -86.963 | -65.182 |
Wednesday, March 19, 2025 05:10 PM
EDT Cathie Wood’s ARK Investment bought 437K shares of Absci (ABSI) todayLight Up your Portfolio with Spark:Easily identify stocks' risks ...
|
Wednesday, March 19, 2025 02:49 PM
The company also announced a collaboration with chipmaker AMD to power its advanced de novo AI antibody design models, as well as AI biotechnology company Owkin to co-develop therapeutic candidates ...
|
Wednesday, March 19, 2025 05:15 AM
Absci reported quarterly losses of 25 cents per share which missed the analyst consensus estimate of 23 cents per share. This is unchanged from the same period last year. The company reported ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
19/03/25 | 3.00 | 3.09 | 2.81 | 2.98 | 5,910,308 |
18/03/25 | 3.14 | 3.149 | 2.96 | 3.08 | 4,643,473 |
17/03/25 | 3.20 | 3.32 | 3.115 | 3.21 | 3,119,300 |
14/03/25 | 2.975 | 3.205 | 2.9025 | 3.14 | 5,130,965 |
13/03/25 | 3.14 | 3.18 | 2.90 | 2.90 | 2,994,404 |
12/03/25 | 3.07 | 3.26 | 3.055 | 3.12 | 3,268,927 |
11/03/25 | 3.03 | 3.09 | 2.865 | 2.95 | 4,467,261 |
10/03/25 | 3.06 | 3.14 | 2.96 | 3.06 | 4,233,689 |
07/03/25 | 3.10 | 3.225 | 3.031 | 3.12 | 2,715,360 |
06/03/25 | 3.21 | 3.26 | 3.02 | 3.10 | 4,784,889 |
|
|
||||
|
|
||||
|
|